Cargando…
Small molecule PROTACs: an emerging technology for targeted therapy in drug discovery
Curing malignant carcinomas is a grand ambition in the development of human health. Over the past decades, targeted therapies have become one of the most successful ways of achieving this. Of these approaches, small molecule inhibitors and monoclonal antibodies are two major methods, however several...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society of Chemistry
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064693/ https://www.ncbi.nlm.nih.gov/pubmed/35519875 http://dx.doi.org/10.1039/c9ra03423d |